The Toronto-based firm recently received the first set of orally dissolvable thin film strips that will deliver psilocybin and is working with the...
Small caps
Pharma & Biotech
Cannabis
Small caps
Small caps
Bioasis on a roll after Chiesi validates the power of its technology to propel drugs across the blood-brain barrier
Bioasis will get an upfront payment of $3 million from Chiesi and may also be eligible to...
Zoetic grows its own hemp and sells CBD products in the US, UK and Europe
The firm is one of the largest operators of medical health & wellness centers in the US,...
Shareholders and others will have the opportunity to engage with CEOs from AIM ImmunoTech, Heat...
The firm's CEO John Arbuthnot attributes his company’s success in part to a more metered growth...
Willow Biosciences (TSE: WLLW-OTCQX: CANSF) President and CEO Trevor Peters joined Steve Darling from Proactive with news the company has successfully developed a scalable process for producing cannabigerol with greater than 99% purity and no detectable THC at 500-litre scale. Peters...
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
